Risultati della ricerca - Frédérique Penault‐Llorca

Raffina i risultati
  1. 1
    Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective

    Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective di Frédérique Penault‐Llorca, Giuseppe Viale

    Pubblicazione 2012
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer

    aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer di Anne Cayre, Fabrice Rossignol, Eric Clottes, Frédérique Penault‐Llorca

    Pubblicazione 2003
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Testing algorithm for identification of patients with TRK fusion cancer

    Testing algorithm for identification of patients with TRK fusion cancer di Frédérique Penault‐Llorca, Erin R. Rudzinski, Antonia R. Sepulveda

    Pubblicazione 2019
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  4. 4
    Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells

    Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells di Abderrahim El Guerrab, Mahchid Bamdad, Yves‐Jean Bignon, Frédérique Penault‐Llorca, Corinne Aubel

    Pubblicazione 2020
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Treatment of gastric adenocarcinoma: A rapidly evolving landscape

    Treatment of gastric adenocarcinoma: A rapidly evolving landscape di Julien Taı̈eb, Jaafar Bennouna, Frédérique Penault-Llorca, Debora Basile, Emmanuelle Samalin, Aziz Zaanan

    Pubblicazione 2023
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  6. 6
    Experts' opinion: Recommendations for retesting breast cancer metastases for HER2 and hormone receptor status

    Experts' opinion: Recommendations for retesting breast cancer metastases for HER2 and hormone receptor status di Frédérique Penault‐Llorca, Renata A. Coudry, Wedad Hanna, R. Yoshiyuki Osamura, Josef Rüschoff, Giuseppe Viale

    Pubblicazione 2013
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer

    Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer di Abderrahim El Guerrab, Mahchid Bamdad, Fabrice Kwiatkowski, Yves‐Jean Bignon, Frédérique Penault‐Llorca, Corinne Aubel

    Pubblicazione 2016
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up di Fátima Cardoso, S. Kyriakides, S. Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Isabel T. Rubio, Sophia Zackrisson, Elżbieta Senkus

    Pubblicazione 2019
    Testo Testo
    Errata/Corrigenda
    Aggiungi alla lista
    Salvato in:
  9. 9
    Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up di Elżbieta Senkus, S. Kyriakides, Frédérique Penault‐Llorca, Philip Poortmans, Alastair M. Thompson, Sophia Zackrisson, Fátima Cardoso

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Erratum to “Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

    Erratum to “Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up” di Fátima Cardoso, S. Kyriakides, Shinji Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Isabel T. Rubio, Sophia Zackrisson, Elżbieta Senkus

    Pubblicazione 2020
    Testo Testo
    Errata/Corrigenda
    Aggiungi alla lista
    Salvato in:
  11. 11
    Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up di Fátima Cardoso, S. Kyriakides, Shinji Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Isabel T. Rubio, Sophia Zackrisson, Elżbieta Senkus

    Pubblicazione 2019
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers

    Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers di Insaf Fkih M’hamed, Maud Privat, Flora Ponelle‐Chachuat, Frédérique Penault‐Llorca, Abderraouf Kénani, Yves‐Jean Bignon

    Pubblicazione 2015
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma

    Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma di Thierry Jardé, Florence Caldefie-Chézet, Mireille Damez, Florence Mishellany, Frédérique Penault‐Llorca, Jacques Guillot, M.-P. Vasson

    Pubblicazione 2008
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Germline mutations of the E‐cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer

    Germline mutations of the E‐cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer di Zeming Xie, Lai Sheng Li, Claire Laquet, Frédérique Penault‐Llorca, Nancy Uhrhammer, Xiao Xie, Yves Jean Bignon

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    SIRT1-dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer

    SIRT1-dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer di Khaldoun Rifaï, Gaëlle Judes, Mouhamed Idrissou, Marine Daures, Yves‐Jean Bignon, Frédérique Penault‐Llorca, Dominique Bernard-Gallon

    Pubblicazione 2018
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Implementing TMB measurement in clinical practice: considerations on assay requirements

    Implementing TMB measurement in clinical practice: considerations on assay requirements di Reinhard Büttner, John Longshore, Fernando López‐Ríos, Sabine Merkelbach‐Bruse, Nicola Normanno, Etienne Rouleau, Frédérique Penault‐Llorca

    Pubblicazione 2019
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up di Elżbieta Senkus, S. Kyriakides, Shinji Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Emiel J. Rutgers, Sophia Zackrisson, Fátima Cardoso

    Pubblicazione 2015
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study

    Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study di Marc J. van de Vijver, Michael Bilous, Wedad Hanna, Manfred Hofmann, Petra Kristel, Frédérique Penault‐Llorca, Josef Rüschoff

    Pubblicazione 2007
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies

    Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies di Thierry Jardé, Florence Caldefie-Chézet, Nicolas Gonçalves-Mendes, Florence Mishellany, Christa Buechler, Frédérique Penault‐Llorca, M.-P. Vasson

    Pubblicazione 2009
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Progresses Toward Precision Medicine in<i>RET</i>-altered Solid Tumors

    Progresses Toward Precision Medicine in<i>RET</i>-altered Solid Tumors di Carmen Belli, Santosh Anand, Justin F. Gainor, Frédérique Penault‐Llorca, Vivek Subbiah, Alexander Drilon, Fabrice André, Giuseppe Curigliano

    Pubblicazione 2020
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: